Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2000
10/17/2000US6133268 1,4-disubstituted piperazines
10/17/2000US6133266 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives
10/17/2000US6133265 Treating physiological disorders associated with an excess of neuropeptide y, such as eating disorders, e.g., obesity, bulimia, and certain cardiovascular diseases, e.g., hypertension
10/17/2000US6132886 N-acrylamido-piperazine
10/17/2000US6132475 For oxidation dyeing of keratin fibers; includes coupler and developer, in which the developer is a substituted 2-(furyl, thienyl, pyrrolyl, or selenophene) p-diaminobenzene derivative of given formula; colorfastness, washfastness
10/12/2000WO2000059906A1 Aminoheterocycle-substituted glycerols
10/12/2000WO2000059883A2 Method for producing n-aryl-aza-heterocycles in the presence of cesium carbonate
10/12/2000WO2000059880A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000WO2000059878A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF
10/12/2000WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's)
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059873A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000WO2000059866A1 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
10/12/2000WO2000059851A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2369005A1 Inhibitors of lfa-1 binding to icams and uses thereof
10/12/2000CA2368240A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000CA2368083A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2360923A1 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate
10/12/2000CA2268590A1 Ion channel modulating compounds and uses thereof
10/11/2000EP1043320A1 New process for producing aminopiperazine derivatives
10/11/2000EP1043310A1 Biphenylamidine derivatives
10/11/2000EP1043308A1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
10/11/2000EP1043307A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
10/11/2000EP1042305A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1041981A2 $i(S)-PROCYCLIDINE FOR TREATING URINARY INCONTINENCE
10/11/2000EP0754672B1 Gamma-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
10/11/2000CN1269775A Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system
10/11/2000CN1269719A Aroylpiperazines for modulating sexual activity
10/11/2000CN1269136A Fluoric alkenyl compound and use as insect repellent agent
10/10/2000US6130242 S-procyclidine for treating urinary incontinence
10/10/2000US6130222 Analgesics
10/10/2000US6130221 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions
10/10/2000US6130220 Enzyme inhibitors
10/10/2000US6130219 Drug resistance and multidrug resistance modulators
10/07/2000CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000WO2000058279A1 Diaryl derivatives and their use as medicaments
10/05/2000WO2000058277A1 Aryl sulfonic acids and derivatives as fsh antagonists
10/05/2000WO2000058273A1 Method of preparing granular n-alkyl-ammonium acetonitrile salts
10/05/2000WO2000058270A2 Hsv primase inhibitors
10/05/2000WO2000058261A1 Solid nitrating reagent
10/05/2000WO2000032569A3 Alpha-sulfin- and alpha-sulfonamino acid amides
10/05/2000DE19913995A1 Verfahren zur Herstellung von körnigen N-Alkylamoniumacetonitril-Salzen A process for the preparation of granular N-Alkylamoniumacetonitril salts
10/05/2000CA2471984A1 Compounds and method for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2368481A1 Method of preparing granular n-alkyl-ammonium acetonitrile salts
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2361366A1 Novel compounds
10/05/2000CA2361016A1 Diaryl derivatives and their use as medicaments
10/04/2000EP1041073A1 Method for producing triethylenediamines and piperazines
10/04/2000EP1040103A1 Anilide derivative, production and use thereof
10/04/2000EP1040095A1 Cyclohexene carboxylates as neuraminidase inhibitors
10/04/2000EP1039902A2 Inhibitors of gap junction communication
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000EP0765311B1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
10/04/2000CN1268938A Aminocycloalkane compounds
10/04/2000CN1268937A Novel compound having effect of promoting neuron differentiation
10/03/2000US6127423 Phenylamidine derivatives, a process for preparing the same and their use as medicaments
10/03/2000US6127415 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/03/2000US6127191 Solid support having plurality of pendant scaffold moieties covalently attached; for synthesis of bioactive molecules
09/2000
09/28/2000WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists
09/28/2000WO2000056707A1 Diaryl thioethers, compositions and uses thereof
09/28/2000WO2000056704A1 Hydroxamic and carboxylic acid derivatives
09/28/2000WO2000056703A1 Inhibitors of the egf-receptor tyrosine kinase and their use
09/28/2000WO2000056702A1 Resorcinol derivatives
09/28/2000WO2000042971A3 Novel cationic 2-sulphonylaminophenols, their use as couplers for oxidation dyeing, compositions containing them and dyeing methods
09/28/2000WO2000018750A8 Chelates comprising chinoid groups as photoinitiators
09/28/2000CA2367963A1 Hydroxamic and carboxylic acid derivatives
09/28/2000CA2356816A1 Inhibitors of the egf-receptor tyrosine kinase and their use
09/27/2000EP1038868A2 Sulfonamides as antiviral agents
09/27/2000EP1038864A1 Novel metalloproteinase inhibitors
09/27/2000EP1037876A1 Biphenyl derivatives as pharmaceuticals
09/27/2000EP1037637A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
09/27/2000EP0848703B1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii
09/27/2000CN1268117A Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
09/27/2000CN1268116A 3-amidinoaniline derivatives activated blood coagulation factor X inhibitors, and intermediates for producing both
09/26/2000US6124493 Process for the preparation of o-chloromethyl-phenylglyoxylic acid derivatives
09/26/2000US6124476 Catalyst ligands, catalyst compositions, catalyst metal complexes and processes for cross-coupling aromatic boron compounds with aromatic halogens or perfluoroalkylsulfonates
09/26/2000US6124462 Preparing arylamine and biaryls
09/26/2000US6124354 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
09/26/2000US6124346 Estrogen agonist/antagonists treatment of atherosclerosis
09/26/2000US6124332 Metalloproteinase inhibitors
09/26/2000US6124329 Metalloproteinase inhibitors
09/26/2000US6124299 Calcitonin mimetics
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124283 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
09/26/2000US6124280 Substituted phenols as novel calcium channel blockers
09/21/2000WO2000055129A1 Dithiocarbonimidate derivatives
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000055122A1 Nitrile derivatives
09/21/2000WO2000054759A2 Lxr modulators
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000DE19912638A1 Naphthylcarbonsäureamid-substituierte Sulfonamide Naphthylcarbonsäureamid-substituted sulfonamides
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2367595A1 Lxr modulators